A BILL 
To increase reporting requirements and transparency require-
ments in the 340B Drug Pricing Program, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Drug Pricing Trans-
4
parency and Accountability Act’’. 
5
02:45 Oct 06, 2021
H5463
2 
•HR 5463 IH
SEC. 2. MORATORIUM ON REGISTRATION OF NEW NON- 
1
RURAL SECTION 340B HOSPITALS. 
2
Section 340B(a) of the Public Health Service Act (42 
3
U.S.C. 256b(a)) is amended— 
4
(1) in paragraph (4)(L), by striking ‘‘A sub-
5
section (d) hospital’’ and inserting ‘‘Subject to para-
6
graph (11), a subsection (d) hospital’’; and 
7
(2) by adding at the end the following: 
8
‘‘(11) MORATORIUM ON REGISTRATION OF CER-
9
TAIN HOSPITALS.—During the 2-year period begin-
10
ning on the date of the enactment of this para-
11
graph— 
12
‘‘(A) an entity described in paragraph 
13
(4)(L) shall not be considered a covered entity 
14
under this section unless such entity was a cov-
15
ered entity on such date (as evidenced by the 
16
entity having been identified as a covered entity 
17
as of such date under the covered entity identi-
18
fication system established under subsection 
19
(d)(2)(B)(iv)); and 
20
‘‘(B) no site shall be added to the covered 
21
entity identification system established under 
22
subsection (d)(2)(B)(iv) or be permitted to 
23
begin participating in the drug discount pro-
24
gram under this section, as a ‘child site’ or oth-
25
erwise, on the basis of association with a cov-
26
02:45 Oct 06, 2021
H5463
3 
•HR 5463 IH
ered entity described in paragraph (4)(L) un-
1
less such site was identified as a child site as 
2
of December 31, 2020, under the system estab-
3
lished under subsection (d)(2)(B)(iv). 
4
‘‘(12) REGULATIONS
TO
BE
ISSUED
DURING 
5
THE MORATORIUM PERIOD TO IMPLEMENT STATU-
6
TORY REQUIREMENTS CLARIFYING HOSPITAL ELIGI-
7
BILITY CRITERIA AND HOSPITAL CHILD SITE STAND-
8
ARDS AND ENHANCING HOSPITAL TRANSPARENCY.— 
9
‘‘(A) ISSUANCE OF REGULATIONS.— 
10
‘‘(i) IN GENERAL.—During the mora-
11
torium period under paragraph (11), the 
12
Secretary shall promulgate regulations 
13
through notice and comment rulemaking to 
14
implement the standards and requirements 
15
described in subparagraph (B). 
16
‘‘(ii) DEADLINE.—Such final regula-
17
tions shall be promulgated and take ef-
18
fect— 
19
‘‘(I) before the end date of the 
20
moratorium described in paragraph 
21
(11); or 
22
‘‘(II) in the event that any of 
23
such regulations have not taken effect 
24
by such end date, the moratorium 
25
02:45 Oct 06, 2021
H5463
4 
•HR 5463 IH
under subparagraph (11) shall be ex-
1
tended until such regulations are final 
2
and effective. 
3
‘‘(iii) LIMITATION.—The authority to 
4
promulgate regulations under this para-
5
graph is limited to setting forth the details 
6
necessary and appropriate to carry out the 
7
requirements of subparagraph (B) effi-
8
ciently, effectively, and in conformity with 
9
such subparagraph. 
10
‘‘(B) STANDARDS AND REQUIREMENTS.— 
11
‘‘(i) HOSPITAL
CHILD
SITE
STAND-
12
ARDS.— 
13
‘‘(I) IN GENERAL.—Hospitals de-
14
scribed in subparagraphs (L) and (M) 
15
of paragraph (4) may register off- 
16
campus outpatient facilities associated 
17
with the hospital (also known as ‘child 
18
sites’) to participate in the drug dis-
19
count program under this section (be-
20
ginning after the moratorium under 
21
paragraph (11) ends), if— 
22
‘‘(aa) the site is listed on the 
23
hospital’s most recently filed 
24
Medicare cost report on a line 
25
02:45 Oct 06, 2021
H5463
5 
•HR 5463 IH
that is reimbursable under the 
1
Medicare program (or, if the hos-
2
pital is a children’s hospital that 
3
does not file a Medicare cost re-
4
port, the hospital submits to the 
5
Secretary a signed statement cer-
6
tifying that the facility would be 
7
correctly included on a reimburs-
8
able line of a Medicare cost re-
9
port if the hospital filed a cost 
10
report); 
11
‘‘(bb) such cost report dem-
12
onstrates that the services pro-
13
vided at the facility have associ-
14
ated costs and charges for hos-
15
pital outpatient department serv-
16
ices under title XVIII of the So-
17
cial Security Act (or, if the hos-
18
pital is a children’s hospital that 
19
does not file a Medicare cost re-
20
port, the hospital submits to the 
21
Secretary a signed statement cer-
22
tifying that the services provided 
23
at the facility include or consist 
24
solely of outpatient services); 
25
02:45 Oct 06, 2021
H5463
6 
•HR 5463 IH
‘‘(cc) the facility is wholly 
1
owned by the covered entity; 
2
‘‘(dd) 
the 
Secretary 
has 
3
made a determination, under the 
4
process 
described 
in 
section 
5
413.65(b) of title 42, Code of 
6
Federal Regulations (or any suc-
7
cessor regulations), that the facil-
8
ity meets the Medicare provider- 
9
based standards under section 
10
413.65 of title 42, Code of Fed-
11
eral Regulations (or any suc-
12
cessor regulations); 
13
‘‘(ee) the facility provides a 
14
full range of outpatient services, 
15
in addition to drugs; and 
16
‘‘(ff) the facility adheres to 
17
the charity care policy and any 
18
sliding fee scale policy of the par-
19
ent hospital. 
20
‘‘(II) DE-REGISTRATION.—If at 
21
any time following registration one or 
22
more of the standards listed above are 
23
no longer satisfied, a registered hos-
24
pital shall immediately notify the Sec-
25
02:45 Oct 06, 2021
H5463
7 
•HR 5463 IH
retary, de-register the facility, and 
1
keep the facility from making any 
2
purchases under the drug discount 
3
program under this section or rep-
4
resenting to third parties that it may 
5
purchase under such program. 
6
‘‘(ii) HOSPITAL
ELIGIBILITY
STAND-
7
ARDS FOR HOSPITALS NOT OWNED OR OP-
8
ERATED BY A UNIT OF STATE OR LOCAL 
9
GOVERNMENT.—For purposes of subpara-
10
graph (L)(i) of paragraph (4): 
11
‘‘(I) A private hospital has been 
12
formally granted governmental powers 
13
by a unit of State or local government 
14
if the Secretary receives a certification 
15
from a State or local governmental 
16
entity that such governmental entity 
17
has formally delegated, through State 
18
or local statute or regulation or, if 
19
permitted by applicable State or local 
20
law, through a contract with a State 
21
or local government, to the hospital 
22
such a power, described in detail in 
23
the certification. 
24
02:45 Oct 06, 2021
H5463
8 
•HR 5463 IH
‘‘(II) A private hospital has a 
1
contract with a State or local govern-
2
ment to provide health care services to 
3
low-income individuals who are not 
4
entitled to benefits under Medicare or 
5
Medicaid if— 
6
‘‘(aa) the hospital submits a 
7
copy of the contract to the Sec-
8
retary for review; 
9
‘‘(bb) the Secretary deter-
10
mines that the contract creates 
11
an enforceable obligation for the 
12
hospital to provide direct medical 
13
care to low-income individuals in-
14
eligible for Medicare and Med-
15
icaid in an amount that rep-
16
resents at least 15 percent of the 
17
hospital’s total costs for all items 
18
and services furnished at such 
19
hospital; and 
20
‘‘(cc) the contract is avail-
21
able to the public as part of the 
22
information describing the hos-
23
pital in the covered entity identi-
24
02:45 Oct 06, 2021
H5463
9 
•HR 5463 IH
fication system established under 
1
subsection (d)(2)(B)(iv). 
2
‘‘(III) If at any time a hospital 
3
not owned or operated by a unit of 
4
State or local government no longer 
5
meets one or more requirements 
6
under subclause (I) or (II), the hos-
7
pital shall immediately notify the Sec-
8
retary, dis-enroll from the drug dis-
9
count program under this section, and 
10
stop making purchases under such 
11
program and representing to third 
12
parties that it may purchase under 
13
such program. 
14
‘‘(iii) HOSPITAL
TRANSPARENCY
RE-
15
QUIREMENTS.— 
16
‘‘(I) HOSPITAL
REQUIREMENTS 
17
TO IDENTIFY SECTION 340B DRUGS.— 
18
In the case of covered entity hospitals 
19
described in subparagraph (L) of 
20
paragraph (4): 
21
‘‘(aa) Claims for covered 
22
outpatient 
drugs 
purchased 
23
under the drug discount program 
24
under this section shall be sub-
25
02:45 Oct 06, 2021
H5463
10 
•HR 5463 IH
mitted to public and private 
1
payors using the 340B modifier 
2
established 
by 
the 
Secretary 
3
under the prospective payment 
4
system for hospital outpatient de-
5
partment services, in conform-
6
ance with paragraph (22) of sec-
7
tion 1833(t) of the Social Secu-
8
rity 
Act, 
subsection 
(h) 
of 
9
1847A, subparagraph (F) of sec-
10
tion 1927(a)(5), and paragraph 
11
(5) of section 1857(g), that is 
12
‘JG’. 
13
‘‘(bb) Such hospitals shall 
14
report to the Secretary on an an-
15
nual basis, in a form and manner 
16
specified by the Secretary— 
17
‘‘(AA) the hospital’s ag-
18
gregate annual revenue from 
19
drugs purchased under the 
20
program under this section, 
21
minus its aggregate annual 
22
acquisition costs for such 
23
drugs, broken out by hos-
24
pital and by each child site; 
25
02:45 Oct 06, 2021
H5463
11 
•HR 5463 IH
‘‘(BB) any dispensing 
1
fees paid by the hospital or 
2
child site to contract phar-
3
macies for such drugs; 
4
‘‘(CC) the patient mix, 
5
broken down by expected 
6
payment source (including 
7
at least the Medicare pro-
8
gram under title XVIII of 
9
the Social Security Act, a 
10
State plan under the Med-
11
icaid program under title 
12
XIX of such Act, private in-
13
surance, and uninsured indi-
14
viduals), for each such hos-
15
pital, and each child site of 
16
the hospital listed in the 
17
covered entity information 
18
system 
established 
under 
19
subsection (d)(2)(B)(iv), and 
20
the costs incurred at each 
21
such hospital and site for 
22
charity care (as described in 
23
line 23 of Worksheet S– 
24
10—Hospital 
Uncompen-
25
02:45 Oct 06, 2021
H5463
12 
•HR 5463 IH
sated and Indigent Care 
1
Data to the Medicare cost 
2
report or as reported in any 
3
successor form); 
4
‘‘(DD) the percent of 
5
total revenues (net of any 
6
discounts) at each site de-
7
rived from infusion or injec-
8
tion of physician-adminis-
9
tered drugs, including any 
10
associated items or services 
11
furnished incident-to the ad-
12
ministration of such drugs; 
13
and 
14
‘‘(EE) with respect to 
15
such hospital and each child 
16
site of the hospital, the 
17
names of all third-party ven-
18
dors or other similar entities 
19
(including split fee vendors 
20
and 
contract 
pharmacies) 
21
that the covered entity con-
22
tracts with to provide serv-
23
ices associated with the pro-
24
gram under this section 
25
02:45 Oct 06, 2021
H5463
13 
•HR 5463 IH
(broken down by covered en-
1
tity and by each child site). 
2
‘‘(II) PUBLIC
AVAILABILITY.— 
3
The Secretary shall make the infor-
4
mation reported to the Secretary 
5
under subclause (I)(bb) available to 
6
the public (with redactions of any in-
7
formation the Secretary determines to 
8
be proprietary or confidential) in an 
9
annual compilation of the reported in-
10
formation available on the internet 
11
website of the Department of Health 
12
and Human Services, and as part of 
13
the information describing the hos-
14
pital and the relevant child site in the 
15
covered entity identification system 
16
established 
under 
subsection 
17
(d)(2)(B)(iv).’’. 
18
SEC. 3. 340B CLAIMS MODIFIER. 
19
(a) MEDICAID.—Section 1927(a)(5) of the Social Se-
20
curity Act (42 U.S.C. 1396r–8(a)(5)) is amended by add-
21
ing at the end the following: 
22
‘‘(F) 340B CLAIMS MODIFIER.— 
23
‘‘(i) IN
GENERAL.—All claims sub-
24
mitted to a Medicaid fee-for-service pro-
25
02:45 Oct 06, 2021
H5463
14 
•HR 5463 IH
gram or a medicaid managed care organi-
1
zation 
(as 
defined 
in 
section 
2
1903(m)(1)(A)) for reimbursement of a 
3
unit of a covered outpatient drug subject 
4
to an agreement under section 340B of the 
5
Public Health Service Act shall include the 
6
340B modifier established by the Secretary 
7
under the prospective payment system for 
8
hospital outpatient department services 
9
under section 1833(t) that is ‘JG’ or the 
10
Submission Clarification Code of ‘20’ de-
11
veloped by the National Council for Pre-
12
scription Drug Programs (NCPDP). 
13
‘‘(ii) DATA
SHARING.—Each single 
14
State agency shall make available to a 
15
manufacturer of a covered outpatient drug 
16
any fee-for-service or managed care claim 
17
for reimbursement for a unit of such drug 
18
for the purpose of verifying the propriety 
19
of any claim for a rebate payment under 
20
an agreement under subsection (b) with re-
21
spect to such drug. At the manufacturer’s 
22
request, in lieu of making such a claim 
23
available to the manufacturer, the single 
24
State agency may instead provide a list of 
25
02:45 Oct 06, 2021
H5463
15 
•HR 5463 IH
claims (and relevant data concerning each 
1
claim) for covered outpatient drugs that 
2
were purchased under an agreement under 
3
section 340B of the Public Health Service 
4
Act or other summary data specified by 
5
the manufacturer. 
6
‘‘(iii) REPORT.—Each single State 
7
agency shall publish an annual report on 
8
utilization of covered outpatient drugs sub-
9
ject to an agreement under section 340B 
10
of the Public Health Service Act by the 
11
Medicaid fee-for-service program or a med-
12
icaid managed care organization (as de-
13
fined in section 1903(m)(1)(A)) during the 
14
preceding calendar year. The State agency 
15
shall not include confidential patient-spe-
16
cific, drug-specific, or manufacturer-spe-
17
cific information in any such annual re-
18
port.’’. 
19
(b) MEDICARE.— 
20
(1) MEDICARE PART B.— 
21
(A) HOSPITAL OUTPATIENT DEPARTMENT 
22
SERVICES.—Section 1833(t) of the Social Secu-
23
rity Act (42 U.S.C. 1395l) is amended by add-
24
ing at the end the following paragraph: 
25
02:45 Oct 06, 2021
H5463
16 
•HR 5463 IH
‘‘(22) 340B CLAIMS MODIFIER.—All claims sub-
1
mitted under the system under this subsection for 
2
reimbursement of a unit of a covered outpatient 
3
drug subject to an agreement under section 340B of 
4
the Public Health Service Act shall include the 340B 
5
modifier established by the Secretary under such 
6
system that is ‘JG’ (or ‘TB’ in the case of a claim 
7
for reimbursement under such system submitted by 
8
a hospital described in subparagraph (M) or (N) of 
9
section 340B(a)(4) of the Public Health Service Act 
10
or a rural sole community hospital described in sub-
11
paragraph (O) of such section).’’. 
12
(B) OTHER
PART
B
CLAIMS.—Section 
13
1847A of the Social Security Act (42 U.S.C. 
14
1395w–3a) is amended by adding the following 
15
new subsection: 
16
‘‘(h) 340B CLAIMS MODIFIER.—All claims submitted 
17
under this part (other than under the prospective payment 
18
system for hospital outpatient department services under 
19
section 1833(t)) for reimbursement of a unit of a covered 
20
outpatient drug subject to an agreement under section 
21
340B of the Public Health Service Act shall include the 
22
340B modifier established by the Secretary under such 
23
payment system that is ‘JG’.’’. 
24
02:45 Oct 06, 2021
H5463
17 
•HR 5463 IH
(2) MEDICARE
ADVANTAGE
AND
MEDICARE 
1
PART D.—Section 1857(e) of the Social Security Act 
2
(42 U.S.C. 1395w–27(e)) is amended by adding at 
3
the end the following new paragraph: 
4
‘‘(5) 340B CLAIMS MODIFIER.—All claims sub-
5
mitted to a Medicare Advantage organization or a 
6
PDP sponsor under this part and part D, respec-
7
tively, for reimbursement of a unit of a covered out-
8
patient drug subject to an agreement under section 
9
340B of the Public Health Service Act shall include 
10
the 340B modifier established by the Secretary 
11
under the prospective payment system for hospital 
12
outpatient 
department 
services 
under 
section 
13
1833(t) that is ‘JG’ or the Submission Clarification 
14
Code of ‘20’ developed by the National Council for 
15
Prescription Drug Programs (NCPDP).’’. 
16
(3) REPORT ON UTILIZATION UNDER MEDICARE 
17
PART
B.—The Secretary of Health and Human 
18
Services shall publish an annual report on utilization 
19
under part B of title XVIII of the Social Security 
20
Act (42 U.S.C. 1395j et seq.) of covered outpatient 
21
drugs purchased subject to an agreement under sec-
22
tion 340B of the Public Health Service Act (42 
23
U.S.C. 256b) during the preceding calendar year. 
24
The Secretary shall not include confidential patient- 
25
02:45 Oct 06, 2021
H5463
18 
•HR 5463 IH
specific, drug-specific, or manufacturer-specific in-
1
formation in any such annual report. 
2
(c) EFFECTIVE DATE.—The amendments made by 
3
this section take effect on the date that is 6 months after 
4
the date of enactment of this Act and apply to claims sub-
5
mitted on or after that date. 
6
SEC. 4. REPORTS TO CONGRESS. 
7
Section 340B of the Public Health Service Act (42 
8
U.S.C. 256b) is amended by adding at the end the fol-
9
lowing: 
10
‘‘(f) REPORTS TO CONGRESS.— 
11
‘‘(1) OIG REPORT.—Not later than 2 years 
12
after the date of the enactment of this subsection, 
13
the Office of the Inspector General shall submit to 
14
Congress a final report on the level of charity care 
15
provided by covered entities described in subpara-
16
graph (L) of subsection (a)(4) and separately by 
17
child sites of such covered entities. 
18
‘‘(2) GAO REPORTS.— 
19
‘‘(A) INITIAL REPORT.—Not later than 1 
20
year after the date of the enactment of this 
21
subsection, the Comptroller General of the 
22
United States shall submit to Congress a re-
23
port— 
24
02:45 Oct 06, 2021
H5463
19 
•HR 5463 IH
‘‘(i) analyzing the State and local gov-
1
ernment contracts intended to satisfy the 
2
requirement under subsection (a)(4)(L)(i) 
3
for a covered entity to qualify as an entity 
4
described in subparagraph (L) of sub-
5
section (a)(4); 
6
‘‘(ii) assessing the amount of care 
7
such contracts obligate such entity to pro-
8
vide to low-income individuals ineligible for 
9
Medicare under title XVIII of the Social 
10
Security Act and Medicaid under title XIX 
11
of such Act; and 
12
‘‘(iii) analyzing how these contracts 
13
define low-income individuals and whether 
14
the Secretary reviews such determinations. 
15
‘‘(B) SUBSEQUENT
REPORT.—Not later 
16
than 2 years after the date of the enactment of 
17
this subsection, the Comptroller General of the 
18
United States shall submit to Congress a final 
19
report on the difference between the aggregate 
20
gross reimbursement and aggregate acquisition 
21
costs received by each such covered entity (in-
22
cluding child sites of such entity) for drugs sub-
23
ject to an agreement under this section.’’. 
24
02:45 Oct 06, 2021
H5463
20 
•HR 5463 IH
SEC. 5. MEDICARE REQUIREMENT FOR HOSPITALS RE-
1
GARDING 340B DRUG INFORMATION. 
2
(a) IN GENERAL.—Section 1866(a)(1) of the Social 
3
Security Act (42 U.S.C. 1395cc(a)(1)) is amended— 
4
(1) in subparagraph (X), by striking ‘‘and’’ at 
5
the end; 
6
(2) in subparagraph (Y), by striking the period 
7
at the end and inserting ‘‘, and’’; and 
8
(3) by inserting after subparagraph (Y), the fol-
9
lowing new subparagraph: 
10
‘‘(Z) in the case of a hospital that is a covered 
11
entity under subsection (a)(4) of section 340B of the 
12
Public Health Service Act, to include in any cost re-
13
port submitted to the Secretary under this title in-
14
formation on— 
15
‘‘(i) the aggregate acquisition costs of the 
16
hospital for drugs, the purchase of which were 
17
attributed to the hospital, during the period 
18
covered by such cost report and for which the 
19
hospital received a discount under such section 
20
340B; and 
21
‘‘(ii) the aggregate revenues the hospital 
22
received from all payors for such drugs, 
23
disaggregated by insurance status (including 
24
the Medicare program, the Medicaid program, 
25
02:45 Oct 06, 2021
H5463
21 
•HR 5463 IH
the Children’s Health Insurance Program, pri-
1
vate health insurance, and uninsured).’’. 
2
(b) EFFECTIVE DATE.—The amendments made by 
3
subsection (a) shall apply to contracts entered into or re-
4
newed on or after the date of the enactment of this Act. 
5
Æ 
02:45 Oct 06, 2021
H5463
